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Large granular lymphocytes (LGL)' are cytotoxic leukocytes with reniform
nuclei and large cytoplasms containing azurophilic granules (1) . These granules
contain cytotoxic moieties that are capable ofmediating target cell death in vitro
(2, 3). Natural killer (NK) cells are LGL that have been implicated in the early
resistance to certain virus infections in murine systems (4). Cytotoxic T lympho-
cytes (CTL) are important later in infection for the clearance of virus and
recovery of the host (5) . Recent work has demonstrated that the CTL generated
in vivo during virus infection acquire the LGL morphology (6) .
The activities ofNK cells andCTL have been extensively studied in the spleens
of mice during infection with several viruses, including lymphocytic choriotnen-
ingitis virus (LCMV) (7) . LCMV-induced interferon (IFN) leads to significant
activation (8), blastogenesis, and proliferation ofNK cells, all of which peak in
the spleen about 3 d postinfection (p .i .) (9-11) . The activity and blastogenesis of
spleen CTL peak later during infection (day 7 p.i .) (9, 10), and this killing is
mediated by effector cells that are virus-specific and restricted in their killing
function by class I antigens of the major histocompatibility complex (MHC) (12) .
The presence ofNK cells andCTL in other compartments of the virus-infected
host has been less well studied . In fact, there has not been a demonstration by
morphology of an accumulation of either NK/LGL or CTL/LGL in diseased
organs . CTL and NK cell activities have been found in the cerebrospinal fluid
during vaccinia virus-induced meningitis (13), andCTL are present in meningeal
exudates during LCMV-induced meningitis (14) . CTL have also been isolated
from the lung during infection with influenza (15) and respiratory syncytial (16)
viruses, but to our knowledge, virus-specific CTL have not been demonstrated
in the virus-infected liver .
The liver is a major organ for the replication of many viruses and the sole
organ for the replication of some . Virus-induced hepatitis is frequently a severe
life-threatening disease affecting millions of people worldwide, but little is known
about the cytotoxic inflammatory cell population within the diseased liver.
Wiltrout et al . (17) have shown the presence of NK/LGL in the livers of mice,
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and the NK cell activity and LGL number were significantly augmented after
administration of certain biological response modifiers. In this report we docu-
ment for the first time that high numbers of LGL accumulate in the liver during
viral infection. An initial wave of NK/LGL is followed by a substantially greater
influx of CTL/LGL. We compare hepatotropic and nonhepatotropic strains of
LCMV (a noncytopathic virus) for their effect on NK cell and CTL accumulation
and activity in the liver. The effect on NK/LGL accumulation stimulated by two
highly cytopathic hepatotropic viruses, mouse hepatitis virus (MHV) and murine
cytomegalovirus (MCMV), is contrasted to that caused by noncytopathic LCMV.
Materials and Methods
Mice.
￿
Mice were used between the ages of 6 and 12 wk. C3H/St male mice were
purchased from West Seneca Laboratories (West Seneca, NY). C57BL/6J, C57BL/6J
beige (bg/bg), and BALE/cJ mice were purchased from The Jackson Laboratories (Bar
Harbor, ME). Athymic nude (nu/nu) and euthymic (nu/+ mice (BALB/c background)
were provided by Dr. C. Biron of our institution.
Viruses.
￿
The hepatotropic WE strain (18) of LCMV (LCMV-WE), the nonhepatotropic
Armstrong strain of LCMV (LCMV-ARM), and Pichinde virus (PV), an arenavirus related
to LCMV, were grown in L-929 cells (8). MHV, A59 strain (19), was a liver-grown stock
propagated in vivo, and MCMV, Smith strain (4), was a salivary gland-grown stock. Mice
were infected intraperitoneally (i.p.) with 105 plaque-forming units (PFU) of LCMV-WE
or 8 X 10' PFU of LCMV-ARM in a volume of 0 .1 ml. MHV was injected intravenously
(i.v.) (3 X 105 PFU), and MCMV (10' PFU) was injected i.p.
Cells.
￿
YAC-1 cells were derived from a Moloney leukemia virus-induced lymphoma
in A/Sn mice (20, 21). These cells were maintained in RPMI 1640 medium (Gibco, Grand
Island, NY) supplemented with antibiotics, glutamine, and 10% heat-inactivated FCS
(M .A . Bioproducts, Walkerville, MD). L-929 cells, a continuous liver cell line from C3H
mice, and the MC57G cell line from C57BL/6 mice, were maintained in minimum
essential medium (MEM) (Gibco) with the same additives listed above . In some cytotoxicity
assays, target cells were infected with virus (0.1 PFU/cell) 48 h before use.
Reagents.
￿
Poly(I-C); Sigma Chemical Co., St. Louis, MO) was injected i.p. (100 kg) 2
d before use of mice.
Antisera.
￿
Rabbit anti-ganglio-tetraosylceramide (anti-asialo GM,) (Wako Chemicals,
Dallas, TX) was used to deplete NK cell activity selectively in vivo and in vitro (22, 23).
For in vivo use, anti-asialo GM, was diluted 1 :10 with RPMI medium, and 0 .2 ml was
injected i.v. Anti-asialo GM, was used in vitro at a dilution of 1 :50. Monoclonal anti-Thy-
1 .2, clone HO-13-4 (24) (used diluted 1:1,500), and J1 Id antibody (25) (used undiluted)
were generously provided by Dr. R. Woodland (University of Massachusetts Medical
Center). Rat monoclonal antibody to Lyt-2, clone 53-6.7 (24), was used undiluted. Fresh
guinea pig serum (GpC) and rabbit serum (RbC) (Pel-Freeze Biologicals, Brown Deer,
WI) were used as sources of complement (C). Effector cells (see below) were treated with
antibody reagent for 30 min at 4'C and then washed. In antibody-plus-C depletion
studies, cells treated with anti-Lyt-2 were further treated (to improve C fixation) with a
1 :50 dilution of monoclonal mouse anti-rat immunoglobulin, MAR 18 .5 (26), for an
additional 30 min at 4°C and then washed. All cells were resuspended in C for 30 min at
37 ° C, washed, resuspended to equal volume, and used in cytotoxicity assays (see below).
Preparation of Effector Cells.
￿
Spleen cells were obtained by gently dissociating aseptic-
ally removed spleens between two glass microscope slides. Erythrocytes were lysed by
treatment with 0.84% ammonium chloride. The leukocytes were washed, counted, and
resuspended in serum-containing medium at the desired concentration .
Effector cells were prepared from livers after in situ enzyme perfusion (27) with
modifications. Mice were anesthetized with sodium pentobarbital (1 mg, i .p.), the abdom-
inal cavity was exposed by a ventral midline incision, and the intestines were lifted to
expose the portal vein. A silk suture ligature was loosely placed around the portal vein
0 .5 cm from the liver. The portal vein was then catheterized with polyethylene tubingMcINTYRE AND WELSH
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(0.58 mm inner diam, 0 .965 mm outer diam; Becton, Dickinson & Co., Parsippany, NJ),
the ligature was tightened, and the abdominal aorta was transected. Perfusion (2.5 ml/min,
5 min) was begun with heparinized (10 U/ml), Cat+- and Mgt+-free HBSS (Gibco) at
37°C. This initial perfusion served to flush peripheral blood from the organ. Only livers
that were well blanched were used for further study. The perfusate was changed to
prewarmed HBSS containing 0.05% (wt/vol) collagenase (type 1 ; Sigma Chemical Co.)
and 0.05% (wt/vol) neutral protease (dispase, grade II; Boehringer Mannheim, Indian-
apolis, IN), and the perfusion was continued for an additional 10 min. The liver was then
excised and teased apart with forceps in HBSS containing deoxyribo-
nuclease (100 U/ml, type 1 ; Sigma Chemical Co.) on ice for 15 min. The liver cell
suspension was passed through nylon mesh to remove clumps and pelleted at 1,000 g.
The pellet was resuspended in minimal volume (0.5-0.75 ml) and mixed with isotonic
30% metrizamide (Sigma Chemical Co.) in Gey's solution (Gibco) at a ratio of seven parts
metrizamide solution to five parts liver cell suspension (17). This mixture was transferred
to a centrifuge tube, overlaid with 2 ml of PBS, and centrifuged for 20 min at 1,500 g at
10' C. The nonparenchymal cell layer was harvested from the interface, washed, counted,
and resuspended to the desired concentration. This procedure routinely yielded at least
2-5 X 10 nonparenchymal cells per liver from control mice.
Fluorescence-activated Cell Sorting (FRCS). Liver leukocytes were stained for FAGS
analysis and were sorted using rat monoclonal antibody 53-6.7 against Lyt-2 followed by
F(ab')1 mouse anti-rat immunoglobulin conjugated with fluorescein isothiocyanate (Jack-
son Immunoresearch Laboratories, Inc., Avondale, PA). Analysis and sorting were per-
formed on a FACS 440 (Becton-Dickinson FAGS Systems, Mountain View, CA) at a laser
output of 300 mW at 488 nm with green fluorescence collected through a DF 530/30
filter. Cells were separated into fluorescence-negative and fluorescence-positive popula-
tions at a flow rate of 2-2 .5 X 10' cells/s.
Cell Morphology.
￿
1-3 X 109 of the nonparenchymal cells were centrifuged onto glass
slides in a cytocentrifuge (Shandon Southern Instruments, Inc., Sewickley, PA) and stained
with Wright's and Giemsa solutions. 200-500 cells were counted under oil immersion
microscopy for each effector cell population studied. These preparations were >95%
leukocytes by morphologic criteria .
Cytotoxicity Assay.
￿
Target cells (106) were labeled with 100 UCi "Cr (New England
Nuclear, Boston, MA) for 1 h at 37°C, washed, and mixed with effector cells in
quadruplicate in round-bottomed microtiter wells (Costar, Cambridge, MA) at 109 target
cells per well in a total volume of0.2 ml. For spontaneous release determinations, medium
was added without effector cells. NP-40 (1%) was added for maximum release determi-
nations. The plates were incubated for 4-12 h at 37°C in a humidified atmosphere of
5% CO, and 95% air . At the end of incubation, plates were centrifuged at 500 g for 5
min, and 0.1 ml of the supernatant was removed and counted in a Beckman gamma
counter (model 5500; Beckman Instruments, Inc., Palo Alto, CA). The coefficient of
variation among quadruplicate wells was <5% . Data were expressed as percent specific
51Cr release: 100 X (cpm experimental - cpm spontaneous)/(cpm maximum - cpm
spontaneous). In some experiments that examined CTL activity, lysis was expressed as:
percent virus-specific lysis = percent lysis of infected target - percent lysis of uninfected
target. To compare the total lytic capabilities of effector populations isolated from
different organs, calculations of total lytic units were computed by the formula: total lytic
units = (fraction of targets lysed X number of cells per organ)/(E/T ratio). An E/T ratio
on the linear portion of the cytotoxicity curve was used for these calculations.
Statistical Methods.
￿
Data are presented as mean ± SD. Student's t test was used for
statistical comparisons between groups.
Results
Comparison of Hepatotropic and Nonhepatotropic LCMV Infections.
￿
The induc-
tion of NK cells and CTL activities and the accumulation of LGL in the liver
were studied on days 1-14 p.i. in animals infected i.p. with either LCMV-ARM
or LCMV-WE. LCMV-ARM is generally nonhepatotropic and grows poorly inb
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the liver during acute infection, whereas the LCMV-WE strain is hepatotropic
and replicates in the liver to high titer (18). Both viruses induced an increase in
NK cell activity detected against both YAC-1 and L929 cells by day 1 p.i. that
peaked at days 3-5 p.i. and declined thereafter (Fig. 1 D and E). The appearance
and progressive increase of NK cell activity through day 5 p.i. were paralleled
by a progressive increase in LGL number beginning on day 1 p.i. (Fig. 1 B).
Virus-specific CTL activity began to increase on day 5 p.i. with both viruses and
peaked on day 7 p.i. (Fig. 1 F) . By day 7 p.i., the LCMV-WE infection induced
an average 28-fold increase in the number of liver leukocytes, whereas the
LCMV-ARM infection induced only a fivefold increase (Fig. 1 A). These differ-
ences in total leukocyte number were confirmed histologically: LCMV-WE-
infected livers had markedly greater infiltrations of mononuclear inflammatory
cells than LCMV-ARM-infected livers (not shown). The centers of focal accu-
mulations of mononuclear cells occasionally contained one or two necrotic
hepatocytes with pyknotic nuclei and intensely eosinophilic cytoplasm. Because
LCMV is relatively noncytopathic (28), it is likely that hepatocyte death results
from an immunopathologic mechanism. When the total lytic capacities of the
liver leukocyte populations were calculated, the LCMV-WE infection resulted in
10-fold higher total CTL lytic units on day 7 p.i. than did LCMV-ARM infection
(Fig. 1 H). These levels of day 7 CTL activity closely correlated with the total
numbers of LGL isolated on day 7 from the livers of mice infected with LCMV-
WE or LCMV-ARM (Fig. 1 B).
Characterization of Day 3 and 7 Cytotoxic Effector Cells.
￿
The patterns of cyto-
toxic activities present at days 3 and 7 p.i. (Fig. 1) were suggestive of the NK cell
and CTL lytic profiles reported previously in the spleen (8). To characterize
these effector cell populations further, liver leukocytes were treated with various
antibodies and complement (C) in vitro. The cells remaining after treatment
were tested for cytotoxic activity and were examined for the presence of LGL
on stained cytocentrifuge smears. The data in Table I (experiment 1) indicate
that day 3 cytotoxic activity against YAC-1 cells was completely sensitive to
treatment with anti-asialo GM, + C and slightly reduced by anti-Thy-1 .2 + C.
Treatment with C and J 11 d antibody (recognizing a marker on granulocytes and
B cells [25]) had no effect on lysis. Changes in the number of cells morphologically
identified as LGL paralled the changes in lytic activity: anti-asialo GM, + C
treatment markedly reduced the number of LGL, anti-Thy-1 .2 + C resulted in
a partial depletion (64%), and J 11 d + C was without effect on LGL number.
Thus, the phenotype for the day 3 p.i. effector cells is consistent with the
reported phenotype of NK cells (29): asialo GM,-positive, Thy-1 .2+/-, Jlld-,
YAC-1 killer, and LGL morphology.
FIGURE 1 .
￿
Kinetics of the appearance of LGL and of NK cell and CTL cytotoxic activities
in thelivers of C3H/St mice infected with LCMV-ARM (dotted line) or LCMV-WE (solid line).
(A) Total number of leukocytes per liver. (B) Total LGL per liver. (C) Percent LGL in the
leukocyte population. (D) Percent specific "Cr releasefrom L929 targetsat an effector/target
ratio of 10:1 in a 12-h assay. (E) Percent specific "Cr release from YAC-1 targets at an
effector/target ratio of 10:1 in a 4-h assay. (F) Percent specific "Cr release from LCMV-
infected L929 cells at an effector/target ratio of 10:1 in a 12-h assay. (G) NK cell lytic units
per liver (calculated from percent YAC-1 lysis as described in Materials and Methods). (H)
CTLlytic units per liver (calculated from percent virus-specific lysis as described in Materials
and Methods).1672
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TABLE I
Characterization ofLiver Leukocytes Isolated at Days 3 and 7 p.i. with LCMV-ARM
Liver leukocytes isolated from C3H/St mice at day 3 p.i. (experiment 1) or day 7 p.i. (experiment 2)
with LCMV-ARM were treated with antibody and/or C' as described in Materialsand Methods.
TABLE If
FACS Purification ofLyt-2+ CTL/LGL at Day 7p.i. with
LCMV-ARM
Liver leukocytes from C3H/St mice at day 7 p.i. with LCMV-ARM were
stained with monoclonal anti-Lyt-2 antibody and sorted into Lyt-2+ and
Lyt-2- populations. NK cell assays against YAC-1 targets were run for 4
h at E/T of 3:1, and CTL assays against uninfected and LCMV-infected
L929 cells were run for 14 h at E/T of 3:1 .
Liver leukocytes isolated at day 7 p.i . were treated with antibody reagents
known to react with determinants present on CTL. As shown in Table I (exp.
2), treatments with either anti-Thy-1 .2 + C or anti-Lyt-2 + C significantly
reduced the virus-specific lysis of infected target cells. These treatments also
resulted in the depletion of a significant proportion of the LGL from the effector
cell population.
To further confirm the CTL surface phenotype and LGL morphology of
effector cells obtained at day 7 p.i. with LCMV, liver leukocytes were examined
by FACS analysis after staining with monoclonal anti-Lyt-2 antibody. 27% of the
day 7 p.i. liver leukocyte population was Lyt-2+ (data not shown). FACS-sorted
Lyt-2+ cells were enriched at least twofold for virus-specific lytic activity com-
pared with stained but unseparated cells, whereas NK cell activity was reduced
(Table II). Conversely, while Lyt-2- cells were depleted ofvirus-specific cytotoxic
effectors, they were enriched for cells expressing NK cell activity. Lyt-2+ cells
Exp. Treatment
Percent Specific
lysis at E/T
ratios of:
20:1 7:1
Percent
reduction in LGL
(x105)
1. Day 3 effectors/YAC-1 GpC control 29 12 1.4
targets Anti-asialo GM + GpC 1.0 0.2 0.1(93)
Anti-Thy-1 .2 + GpC 22 10 0.5(64)
RbC control 35 15 1.0
jI ld + RbC 34 15 1.1 (-10)
7:1 2:1
2. Day 7 effectors/per- GpC control 30 17 15
cent virus-specific Anti-Thy-1 .2 + GpC 8.8 0.7 4.5(70)
lysis RbC control 32 15 8.4
Anti-Lyt-2 + RbC 12 2.3 5.5
Cell population Percent LGL
Percent
virus-
specific lysis
percent
lysY
YAG-1
Lyt-2+ 42 57 3.1
Lyt-2- 13 10 16
Unsorted 23 27 6.9TABLE III
Cytotoxicity Pattern ofDay 7 p.i. Effector Cells from LCMV-ARM-
infected Liver
E:T
ratio
McINTYRE AND WELSH
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Percent specific lysis
L929
￿
L929 +
￿
L929 + PV
￿
MC57G +
LCMV LCMV
20
￿
13
￿
59 16
￿
18
7
￿
4.3 37
￿
5.0
￿
4.7
2
￿
2.4 20 -0.6 4.7
Liver leukocytes from C3H/St mice (H-2") at day 7 p.i. with LCMV-ARM
were tested for lytic activity against uninfected L929 cells (H-2°), L929
cells infected with LCMV (L929 + LCMV) or Pichinde virus (L929 +
PV), and MC57G cells (H-26) infected with LCMV (MC57G + LCMV) in
12-h "Cr-release assays.
were enriched almost twofold for cells possessing LGL morphology, and they
accounted for 54% ofall LGL present. Lyt-2- cellswere LGL-depleted compared
with unfractionated cells (Table 11). Thus, CTL activity and cells bearing LGL
morphology were found to copurify in a population ofleukocytes expressing the
CTL marker Lyt-2.
Spleen CTL induced during LCMV infection are virus-specific and H-2-
restricted effector cells (12). When tested for lysis against various targets, liver
effector cells isolated from C3H/St mice at day 7 p.i. had typical CTL-killing
patterns (Table 111). These effectors strongly lysed LCMV-infected histocompa-
tible cells (L929 + LCMV) but not LCMV-infected histoincompatible cells
(MC57G + LCMV). They also exhibited minimal lysis against histocompatible
cells either uninfected or infected with Pichinde virus (L929 + PV). Other
experiments showed that the PV-infected cells were highly sensitive targets for
PV-immune CTL (30). These experiments confirm that the effector cells isolated
from liver at day 7 p.i. with LCMV contain classical virus-specific CTL.
Depletion of LGL In Vivo.
￿
Mice were treated in vivo with anti-asialo GM, at
the time of virus infection, and liver leukocytes and splenocytes were isolated at
day 3 p.i. Table IV (exp. 1) demonstrates that, in vivo, anti-asialo GM, treatment
was highly effective at depleting NK cell activity (YAC-1 lysis) in both the liver
and spleen during virus infection. This treatment also significantly reduced both
the percentage and absolute number of LGL in the liver leukocyte population
without reducing the total number of liver leukocytes present in these animals.
The sensitivity ofthe generation of the day 7 effector cells was similarly tested.
In contrast to the day 3 NK/LGL, the accumulation of day 7 CTL/LGL in the
liver was relatively resistant to a double treatment in vivo with anti-asialo GM,
serum (Table IV, exp. 2). This treatment eliminated most of the relatively low
level of NK-like cytotoxicity against YAC-1 cells without reducing the CTL-like
cytotoxicity on LCMV-infected L929 cells.
LGL Response in C57BL/6J Mice.
￿
To be certain that the differential in the
liver-associated CTL response during LCMV-WE infection vs. LCMV-ARM
infection was not peculiar to the C3H/St mouse strain, C57BL/6J mice were
infected with LCMV-WE or LCMV-ARM, and the CTL responses were com-
pared. Livers of C57BL/6J mice infected with LCMV-WE had significantly1674
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TABLE I V
Effects ofAnti-asialo GM, Treatment In Vivo on Accumulation ofNK/LGL and CTL/LGL in
Liver during LCMV-WE Hepatitis
Total leukocytesper:
￿
Percent
￿
Total LGL
Effectors
￿
LGL
￿
per liver
Liver
￿
Spleen
￿
(liver)
￿
(X 10-5)
(X 10 6)
￿
(X 10-1)
Splenocytes and liver leukocytes were obtained from C3H/St mice (n = 3 per group) at day 3 p.i.
(exp. 1) andat day 7 p.i. (exp. 2) with LCMV-WE. Antiserum-treated mice were injected i.v. with
0.2 ml anti-asialo GM, (1 :10 dilution) at the time of infection (day 0; exp. 1) or at days 0 and 4
p.i . (exp. 2).
* YAC-I assays were run for 4 h at liverleukocyte E/T ratio of 30 and spleen E/T ratio of 100.
$ Percent virus-specific lysis was determined in 16-h "Cr-release assays at liver leukocyte E/T ratio
of 3 and spleen E/T ratio of 11 .
TABLE V
CTL Activity in Livers But Not in Spleens of C57BL/6J Mice Infected with LCMV-WE
Percent virus-specific
￿
Total CTL lytic units
lysis
￿
(X 104)
Liver Spleen Liver Spleen
Control 10±2.8 4.7±1 4.0±1 .4 3.8±0.3 - -
￿
-
￿
-
LCMV-ARM 17±1.4 11±0.7 18±5.7 30±7.1 48±9.9 54±13 55±9.9 114±36
LCMV-WE 63±21 3.611 12±4.2 71±1 .3 25±0.7 13±0.7 108±4.1 8.8±1 .8
Liver and spleen effector cells were isolated at day 7 p.i. Lytic unit calculations are based upon
percentvirus-specific lysis determinations from 5-h "Cr-release assays at liver leukocyte E/T ratio of
20 and spleen E/T ratio of 50.
higher numbers oftotal leukocytes (p < 0.02) and total LGL (p < 0.001), as well
as twofold higher CTL lytic units than did those from LCMV-ARM-infected
mice (Table V). These results were similar to those observed with C3H/St mice
(Fig. 1). Surprising, however, was the finding that this difference in the liver
CTL/LGL activity was manifested despite the very low levels of CTL activity in
the spleens of the LCMV-WE-infected mice (Table V). The spleens from the
LCMV-WE-infected mice were smallerand contained 67% fewer leukocytes than
spleens from LCMV-ARM-infected mice. Thus, C57BL/6J mice infected with
either strain of LCMV were capable of mounting a CTL response, but that
response was concentrated almost exclusively in the livers ofmice infected with
hepatotropic LCMV-WE, whereas the CTL responsepredominated in the spleens
ofmice infected with nonhepatotropic LCMV-ARM .
Thymic Dependence ofLGL Accumulation.
￿
The reason for the large increase in
total liver leukocytes after LCMV-WE infection as compared with LCMV-ARM
infection (Fig. 1, Table V) was unclear. To determine whether specific T cell-
mediated immunity played a role in this difference, T cell-deficient BALB/c
nu/nu mice and immunocompetent nu/+ littermates were infected with either
LCMV-ARM or LCMV-WE, and liver leukocytes were isolated at day 7 p.i. The
data in Table VI indicate that the T cell-sufficient nu/+ mice infected with
Anti- Percent YAC-I lysis* Total Total Percent virus-spe-
Exp. asialo
GM, Liver Spleen
leukocytes
per liver
(X 10-6)
Percent
LGL
LGL per
liver
(X 10-5)
cific
Liver
lysis*
Spleen
1.Day3 - 43±11 36±8.3 1.7±0.1 25±1 .1 4.4±0.3 ND ND
+ 1.6 ± 0.6 4.3 ± 0.8 2.0 ± 0.6 5 ± 1 1.0 ± 0.3 ND ND
2.Day7 - 15±3.1 11±3.8 60±8.1 14±3 .8 86±24 41±4 .4 38±10
+ 6.3±0.6 4.3±0.1 59±3.0 12±2 71±16 50±6 .1 40±7McINTYRE AND WELSH
TABLE VI
Inflammatory Cell Responses in Liver at Day 7 p.i. with LCMV-WE
Are Thymus Dependent
BALB/c nu/nu andnu/+ mice were infected with LCMV-ARM or LCMV-
WE andliverleukocytes were isolated at day7 p.i. as describedin Materials
and Methods.
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TABLE VII
Comparison ofAugmentation ofLiverNK/LGL by Poly(I-C), LCMV-ARM, MCMV, and MHV
LCMV-WE accumulated more liver leukocytes than did nu/+ mice infected with
LCMV-ARM (p < 0.01). This appeared to be thymus-, and therefore probably
T cell-dependent, as nu/nu mice infected with either LCMV-WE or LCMV-
ARM had lower numbers of liver leukocytes than nu/+ mice infected with
LCMV-WE.
Augmentation ofLiverNK/LGL by OtherVirus Infections or Poly(I-C).
￿
Theeffects
ofpoly(I-C) or infection by several viruses on liver NK/LGL were compared in
different mouse strains (Table VII) . C57BL/6j mice treated with poly LC (exp.
1) or infected with the noncytopathic LCMV-ARM (exp. 2) had comparable
increases (two- to threefold compared with controls) in total LGL and in lysis of
Exp. Strain Treatment
Percent
YAC-1 lysis
Total
leukocytes
per liver
(x 10- 6)
Percent LGL
Total LGL
per liver
(x 10-s)
1 C57BL/6j Control 9.3 t 2.3 3.6 t 0.4 9.0 t 1 .4 3.2 ± 0.2
Poly(I-C) 31 t 7.1 3.0 t 0.8 17 t 0 5.0 ± 1 .3
Poly(I-C) + anti-asialo GMI 1 .0 t 0.4 2.5 ± 0.6 1.5 t 0.7 0.4 t 0.3
2 C57BL/6j Control 7 .5 ± 3.1 7.9 t 0.1 4.0 t 1 4.0 t 1 .4
LCMV-ARM 16±0.6 12±1 .7 4.3±0.6 5.2±0.7
3 C67BL/6J LCMV-ARM 16±4.6 9.2±2.6 9.0t2.6 7.9±0.8
LCMV-ARM + anti-asialo 1 .8 ± 2 9.9 ± 7.3 2.2 t 1 .3 2.2 ± 1 .3
GM,
4 C57BL/6J bg/+ LCMV-ARM 15 ± 4 8.9 ± 3.5 8.3 ± 1,2 7.2 ± 1 .7
bg/bg LCMV-ARM 2.3 ± 3 13 ± 2.3 11 t 2.6 14 ± 3.5
5 C57BL/6j Control 14 ± 0.7 6.7 t 0.6 4.5 ± 0.7 3.0 ± 0.3
MCMV 60±4.9 14±0.2 15±1 .4 21±2.3
6 C57BL/6j Control 3.5 ± 2.8 5.1 ± 0.9 3.0 ± 0 1.5 t 0.3
MHV 73±4.2 26±9.3 11±2.8 33±5
7 C57BL/6j Control 10 ± 2.2 2.6 ± 0.8 4.5 ± 1 1,2 t 0.3
MHV 48±3.6 9.5±2.8 12±3 1215.6
MHV + anti-asialo GM, 4.2 ± 4.9 4.3 ± 0.8 2.3 ± 0.6 2.2 1 0.7
8 C57BL/6j bg/bg Control 0.6 t 0.8 13 ± 2.9 6.5 ± 1 .7 8.4 t 3.2
bg/bg MHV 9.3±3.5 34±5.1 13±1 .5 45±11
9 BALB/cj Control 14 ± 3.8 14 ± 3.8 3.0 ± 1 4.0 t 1 .4
LCMV-ARM 39±13 23±9.5 5.7±1 .5 12±3.3
10 BALB/c nu/nu Control 3.0 t 2.1 5.6 ± 1 .1 6.0 ± 1 .4 3.5 t 1 .5
nu/nu Poly(I-C) 38 t 4.5 5.2 ± 1 .1 17 ± 2.5 9.9 ± 3
nu/nu LCMV-ARM 44 t 5 6.5 ± 1 .1 16 ± 3.1 11 ± 3.9
11 BALB/c nu/+ Poly(I-C) 36 t 2 7.5 ± 0.7 16 ± 3 12 t 2.7
nu/nu Poly(I-C) 55 ± 5,1 5.0 t 0.7 27 t 3.6 14 ± 3.8
Mouse strain Virus strain Total leukocytes per
liver (x 10-6)
nu/nu LCMV-ARM 8.8 ± 1.9
nu/+ LCMV-ARM 12 ± 2.3
nu/nu LCMV-WE 7.9 ± 1
nu/+ LCMV-WE 37 ± 5.81676
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YAC-1 cells. In vivo treatment with anti-asialo GM, serum abrogated NK cell
activity and LGL accumulation in both cases (exps. 1 and 3). However, total
numbers of liver leukocytes in the treated animals were only minimally changed
from control, whether or not the mice received anti-asialo GM, injections .
NK cell-deficient C57BL/6J mice homozygous for the beige mutation (bg/bg)
were compared with NK cell-sufficient bg/+ littermates at day 3 p.i. with LCMV-
ARM for liver NK/LGL lytic activity and cell number (exp. 4). C57BL/6J bg/bg
mice had markedly reduced NK cell activity associated with liver leukocytes,
despite having higher percentages and higher total numbers of LGL than bg/+
mice. However, the majority (76%) of the liver LGL present in the bg/bg mice
bore the atypical morphology characteristic of LGL from beige mutant mice
(31), i .e., one to three abnormally large cytoplasmic granules rather than the
numerous small granules of normal LGL (morphology not shown). The NK cell
activity and accumulation of NK/LGL in the livers of heterozygous bg/+ mice
(exp. 4) were similar to those seen in C57BL/6J (+/+) mice (exps. 2 and 3).
These results showing only modest increases in total leukocyte and LGL
number during LCMV infection contrast with the findings at day 3 p.i. in
C57BL/6J mice infected with the cytopathic hepatotropic viruses, MCMV (exp.
5) or MHV (exp. 6). These virus infections increased the total leukocyte number
two- to fivefold, LGL percentages three- to fourfold, and the total LGL number
from 7- to 22-fold. NK cell activity (YAC-I lysis) was also markedly increased in
the MCMV- and MHV-infected mice. As also shown above for poly(I-C) and
LCMV-ARM, anti-asialo GM, treatment abolished the NK/LGL increases in-
duced by MHV (exp. 7). MHV infection of C57BL/6J bg/bg mice also resulted
in a significant (p < 0.01) increase in NK/LGL in the liver, but these cells were
relatively inefficient in lysing YAC-1 targets (exp. 8).
NK/LGL responses in normal BALB/cJ and in T cell-deficient nude (nu/nu)
BALB/c mice were examined. After LCMV-ARM infection, BALB/cJ mice (exp.
9) were found to produce NK/LGL responses comparable to those seen in either
C57BL/6J or C3H/St mice. In BALB/c nu/nu mice, poly(I-C) treatment and
LCMV-ARM infection induced similar increases (exp. 10). When nu/nu and
nu/+ mice were compared within the same experiment, poly(I-C) treatment
induced higher YAC-1 lysis and higher percent LGL in nu/nu than in nu/+ mice
(exp. 11). This is in agreement with previous observations of higher levels of
resting NK cell activity in nu/nu than in nu/+ mice (32).
Thus, these experiments (Table VII) demonstrate that NK cell activity and
LGL numbers in the liver are increased early after virus infection or treatment
with the IFN-inducer poly(I-C). These NK/LGL increasesoccur in several strains
of mice, including strains with genetic defects in NK cells (bg/bg) and T cell
(nu/nu) activity.
Discussion
This is the first demonstration of the accumulation of both NK/LGL and
CTL/LGL in the liver during a virus infection. The accumulation of these cells
correlates with the appearance of NK cell and CTL cytotoxic activities. During
the early course of infection, cytopathic viruses induce more extensive NK/LGL
responses in the liver than do noncytopathic viruses. Infection with the hepato-
tropic LCMV-WE strain results in a significantly greater CTL/LGL response inMcINTYRE AND WELSH
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the liver on day 7 p.i. than does infection with thenonhepatotropic LCMV-ARM
strain.
The NK cell activity in the liver is similar to the NK cell activity reported in
the spleen during LCMV infection (8). The phenotype of the liver-derived NK
cells is asialo GM,-positive, Thy-1.2+1-, and J11 d-, and the cell is contained
within a population of leukocytes bearing the LGL morphology (Table I) . Other
experiments showed that liver NK/LGL activated in vivo by poly(I-C) treatment
or MHV infection could be enriched in plastic-nonadherent cell populations
(data not shown). The early appearance (day 1-2 p.i.) of augmented NK cell
lytic activity in the liver is also seen in the spleen (8), where activity peaks around
day 3 p.i. and then declines. Furthermore, the liverleukocytes contain "activated"
NK cells at day 3 p.i. as evidenced by their ability to lyse L929 cells, a target
resistant to "endogenous" NK cell-mediated lysis (Fig. 1 D). The lysis of NK cell-
sensitive YAGI cells by liver leukocytes continues to remain above endogenous
levels on day 7 p.i. with LCMV-ARM (Fig. 1 E), but lysis of the more resistant
L929 cells is declining (Fig. 1D). This prolonged elevation of NK cell-mediated
lysis against YAGI cells has also been observed in peripheral blood (33) . The
circulating NK cells at day 7 p.i. are lytically active against YAGI targets but
they have lost their ability to lyse the more resistant L929 cells (33) . Thus, the
high NK cell-mediated lysis against YAGI cells seen in the liver and blood at
day 7 p.i. is more likely due to the high NK cell number rather than to an
activated state of the NK cell population. This may reflect the fact that IFN
levels, required for NK cell activation, decline after 3 d p.i. (8).
The early cellular (NK/LGL) immune responses in the liver after nonhepato-
tropic LCMV-ARM and hepatotropic LCMV-WE infections are quite similar,
with NK cell activities and LGL numbers being relatively parallel for the two
infections through day 5 p.i. (Fig. 1) . This may indicate that the augmentation
of NK cell activity and number in the liver is due to systemic effects of IFN
rather than to virus replication in the liver. The IFN-inducer poly(I-C) stimulates
comparable increases in NK cell activity and number (Table VII). In contrast,
MHV and MCMV, which cause highly cytopathic infections o£ hepatocytes,
stimulate much higher levels of NK/LGL in the liver (Table VII). This is also
apparent in beige mutant mice which, despite having defective NK cell function,
respondto cytopathic MHV infection with large numbers of abnormal NK/LGL.
In these circumstances, the presence of the virus, by virtue of its lysing target
cells, may provide an important stimulus for NK cell accumulation . Bukowski et
al. (4) demonstrated that NK cells play a role in the early resistance to MCMV
infection, and suggested that NK cells may provide resistance against MHV
infection as well (23) . In contrast, LCMV infection does not seem to be regulated
by NK cells (4, 23). The tendency of a particular virus infection to attract a
significant number of NK/LGL to a site of virus replication may be one factor
in determining its sensitivity to NK cell-mediated antiviral resistance.
Several lines of evidence support the notion that the CTL lytic activity of liver
leukocytes is being mediated by cells with an LGL morphology : (a) the CTL
activity and the LGL present in the liver on day 7 p.i . are mostly resistant to in
vivo treatment with anti-asialo GM I, a treatment that depletes NK/LGL (Table
IV); (b) leukocytes isolated from livers at day 7 p.i . with LGL morphology and
CTL activity are at least partially sensitive to in vitro treatments with anti-Thy-1678
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1.2 + C and anti-Lyt-2 + C (Table I); (c) CTL activity and LGL at day 7 p.i. are
enriched in FACS-sorted Lyt-2+ leukocytes (Table II), and (d) the levels of CTL
activity and numbers of LGL are very closely correlated on days 7-14 p.i. (Fig.
1). Thus, we suggest that virus-specific CTL in the liver at day 7 p.i. are LGL,
and that the activity and number of these cells are directly related to the extent
of virus replication that has occurred in this organ.
The basis for the large inflammatory cell response in the livers of mice infected
with the hepatotropic LCMV-WE was likely to be due either to an enhanced
nonspecific inflammatory cell response that, by chance, included a proportion of
CTL/LGL, or to virus-specific T cells (CTL/LGL ?) homing to the LCMV-WE-
infected liver and generating signals that attracted other inflammatory cells into
the organ. The lack of a large inflammatory cell infiltrate in any strain of mouse
at 3 d p.i . or in nu/nu mice at 7 d p.i . suggests that the T cell hypothesis may be
correct (Table VI). Supporting this hypothesis is that inflammatory responses in
the brain or footpad of LCMV-infected mice are dependent upon the presence
of H-2K- or D-restricted T cells (34, 35). The fact that a higher inflammatory
response in the liver is seen with LCMV-WE than with LCMV-ARM is probably
due to the fact that LCMV-WE replicates to higher titers (>100-fold) in the liver.
The LCMV-ARM infection does not appear to prevent accumulation of leuko-
cytes in the liver, as mice coinfected with both LCMV-ARM and LCMV-WE
accumulate liver leukocytes and LGL comparable with mice infected only with
LCMV-WE (data not shown).
The majority of experimentation in murine viral immunology has relied on
findings obtained predominantly from spleen cells. The data presented in Table
V demonstrate that, under certain circumstances, cytotoxic activity mediated by
spleen cells may not accurately reflect ongoing immune responses elsewhere in
the body. The basis for the markedly reduced spleen CTL response in C57BL/6J
mice infected with LCMV-WE (compared with similarly infected C3H/St) is not
known. Two possibilities are that there is a defect in the spleen for the generation
of LCMV-specific CTL under these conditions of LCMV infection, or else the
liver may serve as a stimulus to rapidly recruit CTL out of the spleen. These
findings underscore the importance of examining other compartments of the
virus-infected host for signs of a localized immune response, especially if the
virus exhibits specific tissue tropism(s).
We have shown that during virus infection two waves of LGL influx occur in
the liver, and they are associated with the pathologic features of viral hepatitis.
The first of these is a thymus-independent population of NK/LGL, which is
significantly larger in cytopathic virus infections than in noncytopathic virus
infections. The second wave of LGL is a thymus-dependent influx occurring
later during infection and containing Lyt-2+ CTL/LGL. Significantly greater
numbers of CTL/LGL accumulate in the liver during an hepatotropic virus
infection than during a nonhepatotropic virus infection.
Summary
The immunologic mechanisms involved in virus-induced hepatitis were ex-
amined by measuring the cytotoxic capabilities and the morphologic and anti-
genic phenotypes of leukocytes isolated from livers of virus-infected mice. Large
granular lymphocytes (LGL) of both natural killer (NK) cell and cytotoxic TMcINTYRE AND WELSH
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lymphocyte (CTL) phenotypes were found to accumulate in livers of mice
infected with either the nonhepatotropic Armstrong strain of lymphocytic cho-
riomeningitis virus (LCMV-ARM) or the hepatotropic WE strain (LCMV-WE).
Between days 1 and 5 postinfection (p.i .), both viruses induced a three- to
fourfold increase in NK cell lytic activity in the livers of C3H/St mice and a
three- to fourfold increase in the number of LGL in the organ. These LGL were
characterized as NK cells on the basis of cell surface antigens, kinetics of
appearance, target cell range, and morphology. By day 7 p.i., virus-specific, H-
2-restricted, Thy-1 +, Lyt-2+, CTL activity was present in the liver, and its
appearance correlated with a second wave of LGL accumulation. CTL activity,
total leukocyte number, and CTL/LGL number were at least fivefold higher in
the livers of mice infected with LCMV-WE than with LCMV-ARM. The dramatic
LCMV-WE-induced day 7 increases in total leukocytes and LGL were absent in
athymic nude (nu/nu) mice, suggesting that the increases were T cell-dependent.
LCMV-ARM infection of C57BL/6 mice induced significant spleen CTL activity
but little liver CTL activity, whereas LCMV-WE infection resulted in significant
liver CTL activity but minimal spleen CTL activity.
Mice infected with the cytopathic hepatotropic viruses, mouse hepatitis virus
(MHV) and murine cytomegalovirus (MCMV), experienced much greater in-
creases in liver NK/LGL by day 3 p.i. than did mice infected with LCMV or
injected with the interferon-inducer poly(I-C). MHV-infected mice homozygous
for the beige (bg/bg) mutation also exhibited significant increases in liver
NK/LGL cell number and activity, although the activity was less than heterozy-
gote controls, and the morphology of the LGL granules was aberrant.
These data show that the LGL accumulate in virus-infected organs, in this
case, the liver . An early NK/LGL influx is most pronounced during infection
with cytopathic hepatotropic viruses. This initial influx of NK/LGL is followed
later by an influx of CTL also possessing LGL morphology. The CTL/LGL
response in the liver is significantly greater during hepatotropic virus infections,
even when a strong CTL response in the spleen is lacking.
Receivedfor publication 3 July 1986.
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